Recap Of Thursday's Biotech Catalysts - End Of the Day Summary By: Benzinga via Benzinga August 25, 2022 at 18:43 PM EDT Pfizer (NYSE: PFE) announced positive top-line data from the Phase 3 clinical trialRENOIR investigating its bivalent RSV ... Read More >> Related Stocks: Alterity Therapeutics Ltd ADR Aptinyx Inc Astrazeneca Plc ADR Century Therapeutics Inc Dynavax Technologies Iovance Biotherapeutics Inc Merck & Co Pfizer Stoke Therapeutics Inc